Research ArticleRheumatoid Arthritis

Citrullinated peptide dendritic cell immunotherapy in HLA risk genotype–positive rheumatoid arthritis patients

See allHide authors and affiliations

Science Translational Medicine  03 Jun 2015:
Vol. 7, Issue 290, pp. 290ra87
DOI: 10.1126/scitranslmed.aaa9301
PDF Container

Navigate This Article